Category: In Vitro Diagnostics
United States In Vitro Diagnostics
-
2024-2029 Chlamydia Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Chlamydia tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
2024-2029 Cyclospora Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Cyclospora tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024-2029 Gonorrhea Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Gonorrhea tests performed in the following market segments: Birth Centers - ... Read More
-
2024-2029 Lyme Disease Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Lyme Disease tests performed in the following market segments: Hospitals - Commercial/Private Labs ... Read More
-
2024-2029 Mononucleosis Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Mononucleosis tests performed in the following market segments: Ambulatory Care Centers - ... Read More
-
2024-2029 Meningitis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Meningitis tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
2024-2029 Papillomavirus Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Papillomavirus tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024-2029 Salmonella Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Salmonella tests performed in the following market segments: Hospitals - Commercial/Private Labs - ... Read More
-
2024-2029 Shigella Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Shigella tests performed in the following market segments: Hospitals - Commercial/Private Labs - ... Read More
-
2024-2029 Syphilis Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
... volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Syphilis tests performed in the following market segments: Birth Centers ... Read More
-
2024-2029 Tuberculosis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Tuberculosis tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
2024-2029 Coxsackievirus Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Coxsackievirus tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024 United States Anatomic Pathology Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Point-Of-Care (Poc) Testing (Poct) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
-
2024 United States Umbilical Cord Blood Banking Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
-
2024 United States Animal Therapeutics And Diagnostics Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024-2029 Global Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: US, Europe, Japan - Suppli
... Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities This new report from LeadingMarketResearch.com provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles ... Read More
-
2024-2029 US Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: Supplier Shares and Sales Segm
... Instrumentation and Opportunities About This Report This new LeadingMarketResearch.com presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and ... Read More
-
Animal Health Biotechnology in the US - Industry Market Research Report
... toward companion animals like dogs and cats encourage pet owners to pay premiums for these products. At the same, livestock producers see an invaluable benefit in biotech to protect their animals and investment. Innovative developments ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Medical and Diagnostic Laboratories (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 621500
... countless hours of research. Key Findings: Medical and Diagnostic Laboratories Industry (U.S.) to reach $100,831,383,920 by 2031. Medical and Diagnostic Laboratories Industry (U.S.), including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325413
... forecasts that will save countless hours of research. Key Findings: Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.) to reach $30,177,992,896 by 2031. Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.), ... Read More
-
Laboratory Testing Services in the US - Industry Market Research Report
... ranging from consumer and food products to industrial materials. As consumer goods become increasingly regulated, increased demand for testing services continues. Over the past five years, testing services providers have experienced growth in demand for ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
Blood Transfusion Diagnostics
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$1.7 ... Read More
-
STD Testing
... at a CAGR of 5.2% over the analysis period 2023-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of ... Read More
Research Assistance
